© 2021 MJH Life Sciences and Neurology Live. All rights reserved.
© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Joseph Sullivan, MD, and Elaine C. Wirrell, MD, discuss the diagnosis, management, and treatment of Dravet Syndrome.
June 23rd 2021
Joseph Sullivan, MD, and Elaine C. Wirrell, MD, discuss the presentation of Dravet syndrome in children.
The importance of early diagnosis of Dravet syndrome as well as seizure triggers and comorbidities are discussed by key opinion leaders in the field.
June 30th 2021
Elaine C. Wirrell, MD, explains the increased risk of sudden unexpected death in epilepsy (SUDEP) in patients with Dravet syndrome and how to talk about it with caregivers and families.
Considerations of genetic testing regarding family planning as well as behavioral issues associated with Dravet syndrome.
July 7th 2021
Experts discuss the goals of treatment of patients with Dravet syndrome regarding seizure freedom and seizure burden.
Joseph Sullivan, MD, and Elaine C. Wirrell, MD, discuss the management of seizures for Dravet syndrome with different approved therapies.
July 13th 2021
Elaine C. Wirrell, MD, provides an overview of cannabidiol oral solution for treatment of seizures associated with Dravet syndrome.
Joseph Sullivan, MD, provides an overview of the recent approval of fenfluramine oral solution for the treatment of Dravet syndrome.
July 25th 2021
The impact of new drug approvals on the consensus guidelines for the treatment of Dravet syndrome.
A discussion of new developments for the treatment of Dravet syndrome beyond seizure control including gene editing and therapy.